Development of Product. The Program is directed toward the development of a series of Products that each meet the applicable Specifications set forth in Section A of Attachment 1 (including the documents referenced therein) and is expected to have a duration of twenty (24) months. It is understood and agreed that QED will use its Commercially Reasonable Efforts to complete the Program and deliver a Product that meets the applicable Specifications; delivering a detailed design for each of the Products that satisfies the Specifications detailed in Section A of Attachment 1 and will deliver a prototype of said Product in accordance with the schedule in Section B of Attachment 1. Attachment 1 specifies information to be delivered to QED by ViewRay in order for QED to progress the Program and the dates by which such information will be delivered by ViewRay. QED shall not be responsible for Program delays resulting from delay by ViewRay in delivering information necessary to progress the Program and accordingly a day-for-day adjustment to the schedule set forth in Attachment 1 shall be made for any such delay by ViewRay.
Development of Product. The Program is directed toward the development of a Product that meet the applicable Specifications set forth in Section A of Attachment 1 (including the documents referenced therein) and is expected to have a duration of twelve (12) months. It is understood and agreed that Tesla will use its Commercially Reasonable Efforts to complete the Program and deliver a Product that meets the applicable Specifications; delivering a detailed design for the Product that satisfies the Specifications detailed in Section A of Attachment 1 within six (6) months after the Effective Date and delivering a prototype Product that satisfies the Specifications detailed in Paragraph 2 of Attachment 1 within nine (9) months after the Effective Date.
Development of Product. 3.4.1. TMC shall, subject to the obligations stated in this Article 3 and in Article 5, carry out the development work permitted hereunder within its sole discretion and at its own cost and expense.
3.4.2. TMC shall use Commercially Reasonable Efforts to develop Product up until the stage of Filing of an NDA in each country of the Territory.
Development of Product. The Program is directed toward the development of three prototypes of a Product that meets the applicable Specifications set forth in Attachment 1 (including the documents referenced therein) and is expected to have a duration of four (4) months.
Development of Product. 4.1.1 Starting on the Effective Date, except as set forth in Article 3 above, Company shall have the exclusive right, and sole responsibility and decision-making authority, at Company’s own cost and expense, to research, Develop the Product in the Territory and to conduct (either itself or through its Affiliates, agents, subcontractors and/or Sublicensees) all Clinical Trials and non- clinical studies necessary to obtain Regulatory Approval for Product in the Field in the Territory in accordance with the Development Plan, and to Manufacture Product for Development and Commercialization in the Territory.
4.1.2 Starting on the Effective Date, except as set forth in Article 3 above, Licensor shall retain all other rights not described in Section 2.1 above to research, Develop and Commercialize Product outside the Territory, at its own cost and expense, and to Manufacture Product for Development and Commercialization outside the Territory.
4.1.3 Notwithstanding the foregoing, each Party shall disclose to the other Party all non-clinical and clinical data relating to Product generated by either Party in the Territory and Licensor outside the Territory. Each Party hereby grants the other Party the right to use such data for Development and Commercialization of the Product and to obtain Regulatory Approval by Company in the Territory and Licensor outside the Territory, and to Manufacture Product for Development and Commercialization by Company in the Territory and by Licensor outside the Territory.
Development of Product. 2.5.1 Mortara is responsible for the development of the Software and delivery of the Software to Quinton. Quinton shall provide to Mortara such guixxxxx, inxxxxxxx requirements specifications and other related documents, as may be necessary and appropriate to support the timely development of the Software.
2.5.2 Validation and verification testing shall be defined and testing conducted by Quinton on the Software as delivered by Mortara. Dxxxxx xhe testing period, at its sole cost and expense, Mortara shall provide Quinton with technical assistance to support validxxxxx xnd verification testing process.
2.5.3 The Software as delivered by Mortara will be combined by Quinton with other applications and with hardware to develop and deliver the finished Products to end users. Mortara will provide support to Quinton as appropriate to develop and test the intxxxxxxxn of the Software into the finished Products. Mortara further agrees to support the Software by providing corrections to anomalies and such minor feature enhancements as shall be mutually agreed upon.
Development of Product. 4.1 Epro has developed special know-how in the area of stabilizing folates as well as procedures for the stabilization of the Product. Epro will expand this know-how and bear the costs of the development necessary to file a first patent application.
4.2 Epro will use its best efforts to expand its know-how to develop and optimize the Process for manufacturing the Product via new economic synthetic routes according to the proposals in Schedule 4 as well as include its existing and further explored know-how on the stabilization of the Product. The Costs related to development and manufacture of the Product will be shared between the Parties as set forth in Section 6.
4.3 The ownership and protection of the Intellectual Property related to the Product and Program, as between the Parties, will be governed by Section 10.
Development of Product. The Program is directed toward the development of [***] of a Product that meets the applicable Specifications set forth in Attachment 1 (including the documents referenced therein) and is expected to have a duration of [***].
Development of Product. The parties may mutually agree, through the Joint Steering Committee, to conduct a separate research, development and clinical program for a [**] Product. [**] Until the parties agree to conduct such a program, neither party shall be obligated to allocate or spend any resources on such program. If the Joint Steering Committee recommends that the parties conduct such a program, and the cost of such program exceeds the available Research Funding, the parties will determine how to jointly fund it.
Development of Product. 6 (j) Prohibition on Sales.................................................6 (k)
